Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study.
about
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Phase I study of axitinib and ...... cinoma: Results of EVAX study.
@en
Phase I study of axitinib and ...... cinoma: Results of EVAX study.
@nl
type
label
Phase I study of axitinib and ...... cinoma: Results of EVAX study.
@en
Phase I study of axitinib and ...... cinoma: Results of EVAX study.
@nl
prefLabel
Phase I study of axitinib and ...... cinoma: Results of EVAX study.
@en
Phase I study of axitinib and ...... cinoma: Results of EVAX study.
@nl
P2093
P50
P1476
Phase I study of axitinib and ...... rcinoma: Results of EVAX study
@en
P2093
Adelaïde Doussau
Amaury Daste
Andréas Bikfalvi
Anne Gimbert
Carlos Gomez-Roca
Cathy Quemener
Christine Chevreau
Delphine Pedenon-Périchout
Emmanuelle Chauzit
Jean-Pierre Delord
P356
10.1016/J.EJCA.2017.07.031
P577
2017-09-05T00:00:00Z